{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T23:39:57Z","timestamp":1793489997461,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["16LW0116K"],"award-info":[{"award-number":["16LW0116K"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["161L0114A"],"award-info":[{"award-number":["161L0114A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["82DZD03D03"],"award-info":[{"award-number":["82DZD03D03"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"DFG","doi-asserted-by":"publisher","award":["ZE1037\/1-3"],"award-info":[{"award-number":["ZE1037\/1-3"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010571","name":"BMBF Berlin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001648","name":"European Foundation for the Study of Diabetes","doi-asserted-by":"publisher","award":["01KU1501C"],"award-info":[{"award-number":["01KU1501C"]}],"id":[{"id":"10.13039\/501100001648","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jhep.2024.06.040","type":"journal-article","created":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T12:11:49Z","timestamp":1720267909000},"page":"18-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Induction of steatosis in primary human hepatocytes recapitulates key pathophysiological aspects of metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1016","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7994-4375","authenticated-orcid":false,"given":"Yun","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9791-783X","authenticated-orcid":false,"given":"Pascal","family":"Gottmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0335-128X","authenticated-orcid":false,"given":"Joel","family":"Tissink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2628-8976","authenticated-orcid":false,"given":"Karsten","family":"Motzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6787-7742","authenticated-orcid":false,"given":"Revathi","family":"Sekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5498-8507","authenticated-orcid":false,"given":"Wiebke","family":"Albrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3374-6418","authenticated-orcid":false,"given":"Cristina","family":"Cadenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan G.","family":"Hengstler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Sch\u00fcrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4072-0566","authenticated-orcid":false,"given":"Anja","family":"Zeigerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.jhep.2024.06.040_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/liv.13643","article-title":"Global epidemiology of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis: what we need in the future","volume":"38","author":"Araujo","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2024.06.040_bib2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A\u00a0phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2024.06.040_bib3","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1038\/s41467-018-06356-1","article-title":"Genome-wide analyses identify a role for SLC17A4 and AADAT in thyroid hormone regulation","volume":"9","author":"Teumer","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2024.06.040_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/cts.12839","article-title":"Evolving role for pharmacotherapy in NAFLD\/NASH","volume":"14","author":"Attia","year":"2021","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jhep.2024.06.040_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2818.2012.03675.x","article-title":"3-D PSF fitting for fluorescence microscopy: implementation and localization application","volume":"249","author":"Kirshner","year":"2013","journal-title":"J\u00a0Microsc"},{"key":"10.1016\/j.jhep.2024.06.040_bib6","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.06.040_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101092","article-title":"Dysregulated lipid metabolism links NAFLD to cardiovascular disease","volume":"42","author":"Deprince","year":"2020","journal-title":"Mol Metab"},{"key":"10.1016\/j.jhep.2024.06.040_bib8","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S2213-8587(19)30187-1","article-title":"Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study","volume":"7","author":"Zaharia","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jhep.2024.06.040_bib9","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jhep.2017.10.015","article-title":"Pharmacotherapy for NASH: current and emerging","volume":"68","author":"Konerman","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.06.040_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101122","article-title":"Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans","volume":"50","author":"Pafili","year":"2021","journal-title":"Mol Metab"},{"key":"10.1016\/j.jhep.2024.06.040_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18105227","article-title":"Non-alcoholic fatty liver disease: metabolic, genetic, epigenetic and environmental risk factors","volume":"18","author":"Juanola","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jhep.2024.06.040_bib12","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.3748\/wjg.v13.i26.3540","article-title":"Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease","volume":"13","author":"Qureshi","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2024.06.040_bib13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1053\/j.gastro.2016.05.051","article-title":"Comparison of gene expression patterns between mouse models of nonalcoholic fatty liver disease and liver tissues from patients","volume":"151","author":"Teufel","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2024.06.040_bib14","article-title":"In\u00a0vitro and in\u00a0vivo models of non-alcoholic fatty liver disease: a critical appraisal","volume":"10","author":"Soret","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jhep.2024.06.040_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-1-4939-2074-7_4","article-title":"Immortalized human hepatic cell lines for in\u00a0vitro testing and research purposes","volume":"1250","author":"Ramboer","year":"2015","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jhep.2024.06.040_bib16","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jhep.2015.06.015","article-title":"Structural and functional hepatocyte polarity and liver disease","volume":"63","author":"Gissen","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.06.040_bib17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.yexcr.2016.11.027","article-title":"Functional properties of hepatocytes in\u00a0vitro are correlated with cell polarity maintenance","volume":"350","author":"Zeigerer","year":"2017","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jhep.2024.06.040_bib18","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/s42255-019-0124-x","article-title":"Hepatic Rab24 controls blood glucose homeostasis via improving mitochondrial plasticity","volume":"1","author":"Seitz","year":"2019","journal-title":"Nat Metab"},{"key":"10.1016\/j.jhep.2024.06.040_bib19","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.cmet.2022.09.022","article-title":"Vps37a regulates hepatic glucose production by controlling glucagon receptor localization to endosomes","volume":"34","author":"Sekar","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2024.06.040_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.626805","article-title":"A\u00a0critical perspective on 3D liver models for drug metabolism and toxicology studies","volume":"9","author":"Serras","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jhep.2024.06.040_bib21","doi-asserted-by":"crossref","first-page":"S627","DOI":"10.33549\/physiolres.933224","article-title":"The effect of oleic and palmitic acid on induction of steatosis and cytotoxicity on rat hepatocytes in primary culture","volume":"64","author":"Moravcova","year":"2015","journal-title":"Physiol Res"},{"key":"10.1016\/j.jhep.2024.06.040_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/cells9112458","article-title":"Significance of simple steatosis: an update on the clinical and molecular evidence","volume":"9","author":"Mazzolini","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jhep.2024.06.040_bib23","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/hep.26672","article-title":"Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes","volume":"59","author":"Birkenfeld","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.06.040_bib24","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.2337\/diabetes.48.6.1270","article-title":"Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade","volume":"48","author":"Griffin","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.jhep.2024.06.040_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2005.10.004","article-title":"Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it","volume":"6","author":"Begriche","year":"2006","journal-title":"Mitochondrion"},{"key":"10.1016\/j.jhep.2024.06.040_bib26","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3109\/10715762.2013.830717","article-title":"Mitochondrial dysfunction in non-alcoholic fatty liver disease and insulin resistance: cause or consequence?","volume":"47","author":"Garcia-Ruiz","year":"2013","journal-title":"Free Radic Res"},{"key":"10.1016\/j.jhep.2024.06.040_bib27","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jhep.2022.09.020","article-title":"Mitochondrial alterations in fatty liver diseases","volume":"78","author":"Fromenty","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.06.040_bib28","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3389\/fimmu.2020.01169","article-title":"Crosstalk between liver macrophages and surrounding cells in nonalcoholic steatohepatitis","volume":"11","author":"Li","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2024.06.040_bib29","article-title":"New targets for NAFLD","volume":"3","author":"Parlati","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2024.06.040_bib30","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jhep.2023.03.038","article-title":"An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH","volume":"79","author":"Tacke","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.06.040_bib31","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.cmet.2017.07.009","article-title":"Acetyl CoA carboxylase inhibition reduces hepatic steatosis but elevates plasma triglycerides in mice and humans: a bedside to bench investigation","volume":"26","author":"Kim","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2024.06.040_bib32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/13543784.2020.1668374","article-title":"GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH)","volume":"29","author":"Alkhouri","year":"2020","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jhep.2024.06.040_bib33","doi-asserted-by":"crossref","first-page":"E1796","DOI":"10.1073\/pnas.1520686113","article-title":"Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats","volume":"113","author":"Harriman","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2024.06.040_bib34","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of NAFLD and NASH: clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.06.040_bib35","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s13105-011-0110-6","article-title":"Role of lipid droplet proteins in liver steatosis","volume":"67","author":"Okumura","year":"2011","journal-title":"J\u00a0Physiol Biochem"},{"key":"10.1016\/j.jhep.2024.06.040_bib36","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1136\/gutjnl-2022-327498","article-title":"Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosis","volume":"72","author":"Angelini","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2024.06.040_bib37","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jhep.2024.06.040_bib38","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1089\/thy.2021.0257","article-title":"Functional characterization of the novel and specific thyroid hormone transporter SLC17A4","volume":"32","author":"Groeneweg","year":"2022","journal-title":"Thyroid"},{"key":"10.1016\/j.jhep.2024.06.040_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01951-7","article-title":"A\u00a03D primary human cell-based in\u00a0vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidates","volume":"11","author":"Strobel","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2024.06.040_bib40","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1136\/gut.2006.118059","article-title":"Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity","volume":"56","author":"Malhi","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2024.06.040_bib41","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/toxsci\/kfx289","article-title":"Comparison of hepatic 2D sandwich cultures and 3D spheroids for long-term toxicity applications: a multicenter study","volume":"162","author":"Bell","year":"2018","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jhep.2024.06.040_bib42","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/s-2007-979059","article-title":"Pioglitazone and metformin reverse insulin resistance induced by tumor necrosis factor-alpha in liver cells","volume":"29","author":"Solomon","year":"1997","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jhep.2024.06.040_bib43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cgh.2020.04.067","article-title":"Women have a lower risk of nonalcoholic fatty liver disease but a higher risk of progression vs men: a systematic review and meta-analysis","volume":"19","author":"Balakrishnan","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2024.06.040_bib44","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1111\/liv.14943","article-title":"Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)","volume":"41","author":"Burra","year":"2021","journal-title":"Liver Int"},{"issue":"12","key":"10.1016\/j.jhep.2024.06.040_bib45","article-title":"iPSC-derived hepatocytes generated from NASH donors provide a valuable platform for disease modeling and drug discovery","volume":"9","author":"Gurevich","year":"2020","journal-title":"Biol Open"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882782402347X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882782402347X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T02:58:10Z","timestamp":1773457090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016882782402347X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S016882782402347X"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2024.06.040","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction of steatosis in primary human hepatocytes recapitulates key pathophysiological aspects of metabolic dysfunction-associated steatotic liver disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2024.06.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}